1-5 of 5
Rosalba Miceli, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Intensified Chemo-Immunotherapy Including up-Front Autologous or Allogeneic Stem Cell Transplantation (SCT) for Young Patients with Newly Diagnosed Peripheral T-Cell Lymphomas: Final Results of a Phase II Multicenter Prospective Clinical Trial

Paolo Corradini, MD, Umberto Vitolo, Alessandro Rambaldi, MD, Rosalba Miceli, MD, Francesca Patriarca, MD, Andrea Gallamini, MD, Attilio Olivieri, MD, Fabio Benedetti, MD, Giuseppe Todeschini, MD, Giuseppe Rossi, MD, Guido Parvis, MD, Flavia Salvi, Benedetto Bruno, MD, Luca Baldini, MD, Caterina Patti, MD, Giuseppe Milone, MD, Andrés JM Ferreri, MD, Corrado Tarella, MD, Stefano A. Pileri, MD, Anna Dodero, MD
Journal: Blood
Blood (2012) 120 (21): 1984.
https://doi.org/10.1182/blood.V120.21.1984.1984
Published: 2012
Journal Articles

The Risk of Secondary Myelodysplastic Syndrome/Acute Leukemia Following High-Dose Yttrium-90 Ibritumomab Tiuxetan Is Analogous to That Observed Following High-Dose Chemotherapy: a Matched-Pair Analysis In Non-Hodgkin Lymphoma Patients.

Anna Guidetti, MD, Carmelo Carlo-Stella, MD, Marco Ruella, MD, Rosalba Miceli, MD, Liliana Devizzi, MD, Daniela Sia, PhD, Silvia Locatelli, PhD, Arianna Giacomini, PhD, Michele Magni, MD, Paola Matteucci, MD, Stefano Buttiglieri, PhD, Alessandra Risso, PhD, Luigi Mariani, MD, Roberto Passera, PhD, Massimo Di Nicola, MD, Corrado Tarella, MD, Alessandro M. Gianni, MD
Journal: Blood
Blood (2010) 116 (21): 1289.
https://doi.org/10.1182/blood.V116.21.1289.1289
Published: 2010
Journal Articles

TARC Is Useful as Additional Prognostic Factor for Hodgkin's Lymphoma Outcome.

Simonetta Viviani, MD, Arabella Mazzocchi, Valeria Bonfante, Rosalba Miceli, MD, Davide Dalu, MD, Marina Galbiati, Fernando Ravagnani, Luigi Mariani, Alessandro Massimo Gianni
Journal: Blood
Blood (2009) 114 (22): 1557.
https://doi.org/10.1182/blood.V114.22.1557.1557
Published: 2009
Journal Articles

Long-Term Follow-up of Patients Affected by Relapsed Lymphomas Receiving Reduced-Intensity Conditioning (RIC) Regimen Followed by Allogeneic Stem Cell Transplantation (Allo-SCT): An Update of the Phase II Study of the Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Paolo Corradini, MD, Anna Dodero, MD, Lucia Farina, MD, Roberto Fanin, MD, Francesca Patriarca, MD, Rosalba Miceli, MD, Paola Matteucci, MD, Fabio Ciceri, MD, Rosanna Scime’, MD, Franco Narni, MD, Enrico Pogliani, MD, Anna Locasciulli, MD, Serena Dalto, MD, Cristiana Carniti, PhD, Andrea Bacigalupo, MD, Alessandro Rambaldi, Francesca Bonifazi, MD, Attilio Olivieri, MD, Mats L Brune, MD, Alessandro M. Gianni, MD, Corrado Tarella, MD
Journal: Blood
Blood (2008) 112 (11): 3303.
https://doi.org/10.1182/blood.V112.11.3303.3303
Published: 2008
Journal Articles

Prognostic Value of Positron Emission Tomography (PET) Scan in Patients with Relapsed Hodgkin Lymphoma or Aggressive Non-Hodgkin Lymphoma Receiving Salvage Chemotherapy Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation.

Anna Dodero, MD, Roberto Crocchiolo, MD, Francesca Patriarca, MD, Fabio Ciceri, MD, Nicolo’ Frungillo, MD, Roberto Fanin, MD, Rosalba Miceli, MD, Andrea Assanelli, MD, Raffaella Milani, MD, Flavio Crippa, MD, Paolo Corradini, MD
Journal: Blood
Blood (2007) 110 (11): 3039.
https://doi.org/10.1182/blood.V110.11.3039.3039
Published: 2007